# Multiple Ascending Dose Study of SPC4955 in Healthy Subjects

> **NCT01365663** · PHASE1 · COMPLETED · sponsor: **Santaris Pharma A/S** · enrollment: 18 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** SPC4955
- **DRUG:** SPC4955
- **DRUG:** SPC4955
- **DRUG:** SPC4955
- **DRUG:** SPC4955
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT01365663
- **Lead sponsor:** Santaris Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365663, "Multiple Ascending Dose Study of SPC4955 in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01365663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*